Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 1Suspended 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 10Gastrointestinal 3Breast 2Thoracic 1Other neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Pancreatic Neoplasms 2Cholangiocarcinoma 1

Interventions

Oxaliplatin 780Fluorouracil 638Capecitabine 575Gemcitabine 478Leucovorin 459Bevacizumab 445Irinotecan 444Cisplatin 338Radiotherapy 283Cetuximab 252Paclitaxel 180S 1 (combination) 176pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 131apatinib 131130-nm albumin-bound paclitaxel 128Folfox protocol 121durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106regorafenib 102Surgical Procedures, Operative 102Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Calcitriol × Gastrointestinal × Clear all
NCT00238199 2015-04-24

Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

OHSU Knight Cancer Institute

Phase 2 Completed
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01039181 2009-12-24

Calcitriol in Advanced Intrahepatic Cholangiocarcinoma

National Science and Technology Development Agency, Thailand

Phase 2 Unknown
28 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT00536770 2007-11-06

A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Novacea

Phase 2 Suspended
132 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡